Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Retained Earnings (2018 - 2025)

TELA Bio has reported Retained Earnings over the past 8 years, most recently at $91000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $91000.0 for Q4 2025, up 100.03% from a year ago — trailing twelve months through Dec 2025 was $91000.0 (up 100.03% YoY), and the annual figure for FY2025 was $91000.0, up 100.03%.
  • Retained Earnings for Q4 2025 was $91000.0 at TELA Bio, up from -$388.5 million in the prior quarter.
  • Over the last five years, Retained Earnings for TELA hit a ceiling of $262000.0 in Q3 2022 and a floor of -$388.5 million in Q3 2025.
  • Median Retained Earnings over the past 5 years was -$24000.0 (2021), compared with a mean of -$120.2 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 709.3% in 2022 and later crashed 5724940.0% in 2023.
  • TELA Bio's Retained Earnings stood at -$52000.0 in 2021, then soared by 388.46% to $150000.0 in 2022, then tumbled by 39.33% to $91000.0 in 2023, then tumbled by 394308.79% to -$358.7 million in 2024, then skyrocketed by 100.03% to $91000.0 in 2025.
  • The last three reported values for Retained Earnings were $91000.0 (Q4 2025), -$388.5 million (Q3 2025), and $93000.0 (Q2 2025) per Business Quant data.